Recombinant DNA (rDNA) Technology Market
Recombinant DNA (rDNA) Technology Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Recombinant DNA (rDNA) Technology Market Size and Growth
The Recombinant DNA (rDNA) Technology market is witnessing significant growth driven by advancements in biotechnology, increased funding, and demand for genetic therapies. The market size is projected to reach approximately $15 billion by 2025, reflecting a robust compound annual growth rate, influenced by rising applications across pharmaceuticals, agriculture, and diagnostics.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ F. Hoffmann-La Roche Ltd (Genentech, Inc)
◍ Profacgen
◍ Amgen Inc
◍ Novartis AG
◍ GenScript
◍ Pfizer Inc
◍ Novo Nordisk A/S
◍ Eli Lilly and Company
◍ Sanofi
◍ Biocon
◍ GlaxoSmithKline plc
◍ New England Biolabs.
◍ Cibus
◍ Monsanto Company
◍ Horizon Discovery Group PLC
The recombinant DNA technology market features key players like Roche, Amgen, and Novartis, leveraging rDNA for biopharmaceuticals, diagnostics, and therapeutic innovations. These companies contribute to market growth through advanced genetic engineering and product development. Notable revenue figures include:
- Amgen: $26 billion
- Roche: $74 billion
- Pfizer: $81 billion Request Sample Report
Market Segmentation
By Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
Request Sample Report
By Product
Expression System
Cloning Vector
Market Growth
Request Sample Report
$ X Billion USD
